Quarterly report pursuant to Section 13 or 15(d)

Inventories, net (Tables)

v3.22.4
Inventories, net (Tables)
6 Months Ended
Nov. 30, 2022
Inventories, net  
Summary of Inventories, net of reserves

Inventories were as follows (in thousands):

November 30, 2022

May 31, 2022

Raw materials

$

$

16,264

Work-in-progress

 

 

1,665

Total inventories, net

$

$

17,929

Schedule of remaining shelf life of inventory

Raw Materials

Work-in-progress

(in thousands, Expiration period ending November 30,)

    

Remaining shelf-life (mos)

    

Specialized

Resins

Other

Total Raw Materials

Bulk drug product

Finished drug product

Total inventories

2023

0 to 12

$

4,764

$

16,264

$

-

$

21,028

$

-

$

-

$

21,028

2024

13 to 24

2,511

-

1,590

4,101

1,661

29,142

34,904

2025

25 to 36

189

-

-

189

-

32,343

32,532

2026

37 to 48

2,115

-

-

2,115

-

-

2,115

Thereafter

49 or more

-

-

-

-

-

-

-

Inventories, gross

9,579

16,264

1,590

27,433

1,661

61,485

90,579

Inventory charge

(9,579)

(16,264)

(1,590)

(27,433)

(1,661)

(61,485)

(90,579)

Inventories, net

$

-

$

-

$

-

$

-

$

-

$

-

$

-